Therefore, inhibition of the BMP axis, as well as others such as TGFβ, Notch, Wnt, or Runx2/Cbfa1 signaling, represents a possible option for therapy improvement in MM (112, 117, 118). This evidence concerns the gene RUNX2 and Miyoshi myopathy.